文献速递疼痛医学

α-细辛脑通过LXR依赖途径抑制脊髓内质网应激缓解CCI诱导的神经病理性疼痛

α-Asarone Alleviated Chronic Constriction Injury-Induced Neuropathic Pain Through Inhibition of Spinal Endoplasmic Reticulum Stress in an Liver X Receptor-Dependent Manner.
PubMed 文献 · Anesth Analg · 2018-01-01

本研究在大鼠慢性坐骨神经压迫(CCI)模型中探讨α-细辛脑对神经病理性疼痛的作用。结果显示,20 mg/kg α-细辛脑可显著减轻CCI诱导的机械性异常疼痛和热痛觉过敏,并抑制脊髓内质网应激;LXR拮抗剂SR9243可完全阻断其效应,提示α-细辛脑以LXR依赖方式缓解神经病理性疼痛。

要点

  • α-细辛脑20 mg/kg可缓解CCI大鼠的机械性异常疼痛和热痛觉过敏。
  • α-细辛脑抑制CCI诱导的脊髓内质网应激(PERK-eIF2α、IRE1α、CHOP、XBP-1s)。
  • LXR拮抗剂SR9243完全阻断α-细辛脑的抗内质网应激和镇痛效应。

核心结论

  • α-细辛脑以LXR依赖方式缓解CCI诱导的神经病理性疼痛,可能成为治疗神经病理性疼痛的潜在药物。

研究设计与样本

  • 研究分两部分:第一部分将大鼠分为7组(假手术组、假手术+α-细辛脑20 mg/kg组、CCI组、CCI+溶剂组、CCI+α-细辛脑5、10、20 mg/kg组),术后每日给药,第7天测痛阈并取L3-6脊髓行Western blot和免疫荧光。
  • 第二部分大鼠鞘内置入PE-10管,分为4组(CCI+α-细辛脑20 mg/kg组、CCI+α-细辛脑20 mg/kg+溶剂组、CCI+α-细辛脑20 mg/kg+SR9243组、CCI组),每组5只在鞘内注射1小时后行行为学测试,其余第7天处死行Western blot。

主要发现

  • CCI手术显著诱导机械性异常疼痛和热痛觉过敏。
  • CCI手术显著诱导大鼠脊髓内质网应激激活(PERK-eIF2α、IRE1α、CHOP和XBP-1s)。
  • 20 mg/kg α-细辛脑显著减轻CCI诱导的内质网应激激活。
  • α-细辛脑上调脊髓LXRβ及其下游蛋白表达,LXR拮抗剂SR9243完全抑制其抗内质网应激和镇痛效应。

临床怎么用

  • α-细辛脑在CCI大鼠中表现出LXR依赖的镇痛作用,提示其可能作为神经病理性疼痛的潜在治疗药物,但尚未在人体研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuropathic pain is an intractable and complex disease. Recent studies have shown a close relationship between endoplasmic reticulum (ER) stress and neuropathic pain. Here, we investigated the effect of α-asarone, an ER stress inhibitor, on chronic constriction injury (CCI)-induced neuropathic pain. METHODS: Two parts were included in this study. In part 1, rats were assigned to 7 groups: the sham group, the sham + α-asarone 20 mg/kg group, the CCI group, the CCI + vehicle group, the CCI + α-asarone 5 mg/kg group, the CCI + α-asarone 10 mg/kg group, and the CCI + α-asarone 20 mg/kg group. After surgery, the rats were treated with α-asarone or normal saline daily. Pain thresholds were measured, and samples of the L3-6 spinal cord were taken for western blotting and immunofluorescence on day 7. In part 2, rats were intrathecally implanted with PE-10 tubes and divided into 4 groups: the CCI + α-asarone 20 mg/kg group, the CCI + α-asarone 20 mg/kg + vehicle group, the CCI + α-asarone 20 mg/kg + SR9243 group, and the CCI group. Five rats in each group were separated for behavioral tests 1 hour after intrathecal injection. The rest of them were killed for western blotting on day 7. RESULTS: In this study, CCI surgery significantly induced mechanical allodynia and thermal hyperalgesia. CCI surgery significantly induced activation of ER stress (PERK-eIF2α, IRE1α, CHOP, and XBP-1s) in rats. However, treatment with 20 mg/kg of α-asarone significantly alleviated CCI-induced activation of ER stress. Behavioral results showed that daily treatment with 20 mg/kg of α-asarone significantly alleviated CCI-induced nociceptive behaviors, on day 7 (mechanical allodynia, P = .016, 95% confidence interval, 0.645-5.811; thermal hyperalgesia, P = .012, 95% confidence interval, 0.860-6.507). Furthermore, α-asarone induced upregulated expression of liver X receptor β (LXRβ) and downstream proteins in the spinal cord. The LXR antagonist SR9243 completely inhibited the anti-ER stress and antinociceptive effects of α-asarone in rats. CONCLUSIONS: α-Asarone relieved CCI-induced neuropathic pain in an LXR-dependent manner. α-Asarone may be a potential agent for treatment of neuropathic pain.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Gui Y, Li A, Zhang J, et al. α-Asarone Alleviated Chronic Constriction Injury-Induced Neuropathic Pain Through Inhibition of Spinal Endoplasmic Reticulum Stress in an Liver X Receptor-Dependent Manner. Anesth Analg. 2018. PMID: 29324503. doi:10.1213/ANE.0000000000002792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。